Francesco Grimaldi

Francesco Grimaldi

Auto-generated profile, based on publicly available information

Francesco Grimaldi

Department of Cardiothoracic Sciences, Second University of Naples, Naples, Italy

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2009 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
LSLuca De Santo
Luca De Santo
GRGianpaolo Romano
Gianpaolo Romano
Alessandro Della CorteAlessandro Della Corte
Alessandro Della Corte
VSVincenzo de Simone
Vincenzo de Simone
FGFrancesco Grimaldi
Francesco Grimaldi
MFMarisa de Feo
Marisa de Feo

1 April 2011 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
LSLuca Salvatore De Santo
Luca Salvatore De Santo
GRGianpaolo Romano
Gianpaolo Romano
Cristiano AmarelliCristiano Amarelli
Cristiano Amarelli
CMCiro Maiello
Ciro Maiello
FBFrancesco Baldascino
Francesco Baldascino
GNGianantonio Nappi
Gianantonio Nappi
Objective: Data regarding risks and consequences of acute kidney injury (AKI) after cardiac transplantation are dismissingly few and unclear. This study defined the incidence, risk factors and prognostic implication of AKI in a single-center cohort operated on between January 1999 and December 2008. Methods: Data from 307 consecutive recipients (mean age: 47.42 ± 13.58, 20.5% female, 18.9% diabetics, 19.5% with previous cardiac operations, 26.4% hospitalized, 78.4 ± 33.7 ml min−1 preoperative glomerular filtration rate (eGFR)) were analyzed using multivariable logistic regression modeling. AKI was defined according to RIFLE (Risk, Injury, and Failure; and Loss, and End-stage kidney disease) criteria. Results: RIFLE scores of I or F were detected in 14%, and continuous venovenous hemofiltration was needed in 6.1%. Risk factors for AKI were: previous cardiac operation (odds ratio (OR) 2.35; 95% confidence interval (CI), 1.11–4.9), blood transfusion (OR 1.08; 95% CI, 1.011–1.16), troponin I release >10 (OR 1.031; 95% CI, 1.001–1.064), length of ischemic time (OR 1.008; 95% CI, 1.011–1.16). Overall hospital mortality averaged 7.8% and overall 1-year mortality was 10.4%; both mortality rates increased with each RIFLE stratification (Normal 3.4%, RIFLE R = 7.1%; RIFLE I = 25.7%; and RIFLE F = 37.5% and Normal 5.6%, RIFLE R = 11.8%, RIFLE I = 25.7%, and RIFLE F = 37.5%, respectively). AKI proved independent predictors of both early and 1-year mortality. The burden of AKI significantly affected 1-year kidney function (Δ preoperative GFR − 1-year GFR in AKI vs no AKI = −25.872 ± 22.54 vs −7.968 ± 34.18, p = 0.015). Conclusions: AKI is a highly prevalent and prognostically important complication. Some of the risk factors for AKI identified may be modifiable.

1 October 2012 in Giornale Italiano di Cardiologia
Verified
Journal Article
Closed access
CVCarlo de Vincentiis
Carlo de Vincentiis
ABAndrea Biondi
Andrea Biondi
ASAngela Satriano
Angela Satriano
AVAlessandro Varrica
Alessandro Varrica
STSanti Trimarchi
Santi Trimarchi
AFAlessandro Frigiola
Alessandro Frigiola
La patologia aortica rappresenta un campo di applicazione primario nell’ambito cardiochirurgico. In questo contesto, il segmento aortico considerato si estende dalla valvola aortica sino all’aorta toracica discendente. La porzione di aorta addominale sottodiaframmatica è generalmente, e storicamente, di interesse della chirurgia vascolare. Malgrado gli eccellenti e consolidati risultati ottenuti fino ad oggi nel trattamento delle malattie aortiche toraciche, la mortalità e morbilità correlate alle procedure chirurgiche sono ancora significative, anche per la presenza di pazienti sempre più anziani e con patologie sempre più estese e complesse. Negli ultimi anni, la migliore conoscenza delle problematiche aortiche e la disponibilità di nuovi materiali protesici hanno determinato una sostanziale evoluzione delle terapie adottabili sia in sede valvolare che nel segmento aortico, grazie all’utilizzo di protesi impiantabili tramite cateteri (impianto transcatetere di valvola aortica, riparazione endovascolare di aneurisma dell’aorta toracica). L’individuazione delle giuste indicazioni e i risultati a lungo termine determineranno la reale utilità ed efficacia di tali “nuove” procedure e il loro spazio nell’ambito della terapia di queste malattie.